Hydrochlorothiazide Losartan (Hyzaar, Hyzaar Ds) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrochlorothiazide Losartan products are in shortage in Canada (3 of 35 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A combination of a blood pressure medication and a water pill used to treat high blood pressure.
Products affected
3 / 35
In shortage since
Oct 13, 2021
Reports on file
167
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PMS-LOSARTAN-HCTZ
12.5MG
100MG · TABLET · PHARMASCIENCE INC
DIN 02392232 · since Feb 5, 2026, est. end Jul 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
LOSARTAN HCT
12.5MG
100MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388979 · since Oct 13, 2021, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
LOSARTAN HCT
12.5MG
100MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388979 · since Oct 13, 2021, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
LOSARTAN HCT
12.5MG
50MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388960 · since Oct 13, 2021, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
LOSARTAN HCT
12.5MG
50MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388960 · since Oct 13, 2021, no end estimate · Requirements related to complying with good manufacturing practices.
DIN 02362449 · ended May 12, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Hydrochlorothiazide Losartan is currently affected by 3 active shortage reports filed with Health Canada by PHARMASCIENCE INC, SIVEM PHARMACEUTICALS ULC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrochlorothiazide Losartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).
Recent changes
No changes recorded yet.
Common questions
What is Hydrochlorothiazide Losartan used for?
A combination of a blood pressure medication and a water pill used to treat high blood pressure.
When will Hydrochlorothiazide Losartan be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Hydrochlorothiazide Losartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.